title: Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
abstract: The limitations of antiparkinsonian treatment strategy when using anticholinergic drugs are determined by their side effects induced through excessive inhibition of parasympathetic functions. In the present study we have investigated the peripheral effects of antiparkinsonian agents on blood levels of concomitantly administered neuroleptic drugs. We have compared the anticholinergic and a dopamine mimetic antiparkinsonian agent in their effects on serum neuroleptic activity (SNA) and serum anticholinergic activity (SAA). Sixteen schizophrenic patients on chronic neuroleptic therapy with steady state neuroleptic levels were receiving either amantadine, 200 mg/day, or anticholinergic drugs (trihexyphenidyl, 10 mg/day, or benztropine, 6 mg/day) for the first 2 weeks, after which the amantadine group was crossed over to anticholinergic and the anticholinergic group to amantadine for the following 2 weeks. Blood samples were obtained once a week along with clinical testing. The results indicate that SAA was fivefold higher with benztropine than with trihexyphenidyl and that amantadine had no effect on SAA. Moreover, SNA was not altered either by anticholinergics or amantadine coadministration, indicating that the therapeutic blood neuroleptic levels are not compromised by antiparkinsonian administration.
mesh_terms: D000328:Adult; D000547:Amantadine / Q000097:blood / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000097:blood / Q000494:pharmacology*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000517:prevention & control; D001590:Benztropine / Q000097:blood / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011869:Radioligand Assay; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D014282:Trihexyphenidyl / Q000097:blood / Q000494:pharmacology
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D001590:Benztropine; D014282:Trihexyphenidyl; D000547:Amantadine